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Lesional psoriatic epidermis displays a number of phenotypic changes that are 
distinct from the differentiation program found in normal interfoiiicular epidermis.
In psoriatic epidermis, keratinocytes are hyperproliferative and several differentia­
tion-associated molecules are expressed that are absent in normal skin (e.g., 
cytokeratins (CK) 6, 16, and 17, and the epidermal proteinase inhibitor SKALP/ 
elafin). In addition, several molecules which are normally restricted to the stratum 
granulosum are strongly upregulated in the stratum spinosum (e.g., psoriasis- 
associated fatty acid binding protein (PA-FABP), psoriasin, involucrin, and trans­
glutaminase). The aim of this study was to develop in vitro culture systems which 
(a) would allow to study the induction of normal and psoriatic differentiation 
pathways, and (b) would be amenable for screening of antipsoriatic drugs. Here 
we have investigated several models for induction of differentiation with respect 
to the expression of markers for the normal and psoriatic phenotype. Cell cycle 
parameters and expression levels of CK1, CK10, CK16, SKALP/eiafin, transglutam­
inase, involucrin, psoriasin, and PA-FABP were assessed in these models using 
flow cytometry, immunocytochemistry, and Northern blot analysis. W e observed 
that induction of differentiation with fetal calf serum resembled the psoriatic 
phenotype (sustained hyperproliferation; high levels of CK16, SKALP/elafin, trans­
glutaminase, and involucrin; moderate psoriasin expression), whereas differentia­
tion induced by growth factor depletion in a confluent culture resembled the 
normal differentiation phenotype (low proliferative rate; high expression levels 
of CK1 and CK10; moderate expression of involucrin and transglutaminase; low 
expression levels of SKALP/elafin and CK16; absence of psoriasin). We propose 
that these models can be used to study expression and pharmacological modula­
tion of selected differentiation genes and the coordinated expression of sets of 
genes associated with epidermal differentiation programs. © 1996 Wiiey-Liss, inc.
Human epidermis is a stratified squamous epithe­
lium with keratinocytes as the main cell type. To main­
tain normal epidermal integrity, keratinocytes must 
proliferate at an appropriate rate and differentiate ac­
cording to an orderly sequence of events, the program 
of terminal differentiation (reviewed in Watt, 1989; 
Fuchs, 1990). This program is characterized by an out­
ward migration of keratinocytes from the proliferating 
basement-membrane-anchored basal layer to the spi­
nous, granular, and finally cornified layers. During 
their movement through the epidermis, keratinocytes 
undergo a complex program of terminal differentiation, 
also known as keratinization. As part of this matura- 
tional program, basal keratinocytes express cytokera­
tins (CK) 5 and CK14. During their movement to the 
suprabasal spinous layer, keratinocytes start to ex­
press differentiation-specific proteins such as CK1 and 
CK10. Finally, keratinocytes reach the granular layer, 
where a new set of genes, including involucrin, filag- 
grin, and loricrin is expressed. The differentiating cells
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become permeable and transglutaminase is activated 
by the influx of calcium ions into the cells resulting in 
biochemically cross-linking the envelope proteins. This 
highly coordinated process finally leads to a layer of 
dead cells which form the protective covering of the 
skin (Fuchs, 1990).
Lesional psoriatic epidermis displays a number of 
phenotypic changes that are distinct from normal inter- 
follicular epidermis. In lesional psoriatic epidermis, the 
number of cycling cells is dramatically increased (Van 
Erp et al., 1989), and a number of molecules that are 
absent in normal skin are strongly expressed (e,g,, CK 
6, CK 16, and CK17 (de Jong et al., 1991; Weiss et al., 
1984; De Mare et al., 1989), and the epidermal protein­
ase inhibitor SKALP/elafin which we and others have
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recently described (Alkemade et al., 1994; Molhuizen 
et al., 1993; Schalkwijk et al., 1990; Wiedow et al.,
1990). In addition, several molecules have a restricted 
expression pattern in normal skin, but are highly 
upregulated in psoriatic skin. These include psoriasis- 
associated fatty acid binding protein (PA-FABP) (Mad­
sen et al., 1992), involucrin (Fujimoto et al., 1993; Ber­
nard et al., 1988), transglutaminase (Bianchi et al., 
1994; Michel et al., 1992), psoriasin (Madsen et al.,
1991), transforming growth factor a (TGF-a) (Turbitt 
et aL, 1990; Elder et al., 1989), amphiregulin (Cook et 
al., 1992), epidermal growth factor receptor (EGF-R) 
(Nanney et al., 1992), calgranulins A and B (reviewed 
in Madsen et al., 1992), interleukin Ira (Hammerberg 
et al., 1992), interleukin ip (Schmid et al., 1993), in­
terleukin 6 and 8 (Nickoloff et al., 1991; Grossman et 
al., 1989), GRO oc/p/y (Tettelbach et al., 1993), and fi- 
bronectin (Bernard et al., 1988). Recently it has been 
described that oc5px integrins show a sustained expres­
sion in psoriatic epidermis (Hertle et al., 1995; Pelle­
grini et al., 1992). A few molecules are reported to be 
downregulated in psoriatic epidermis compared to nor­
mal epidermis (e.g., interleukin la; Gearing et al., 
1990). At present it is not clear whether the altered 
expression levels of these molecules are causally in­
volved in the pathogenesis of psoriasis, or are mere 
epiphenomena not directly related to the disease pro­
cess. The expression patterns of these molecules are 
not psoriasis-specific and can be found in keratinocytes 
from normal individuals during pathological conditions 
(e.g., wound healing and inflammation; Phillips et al., 
1990; Hertle et al., 1992) or in cell culture as we de­
scribed before (Alkemade et al., 1994).
In order to study cell biological processes involved in 
the transition from normal to psoriatic differentiation 
(as seen in disease processes) and vice versa (as seen 
during healing of a psoriatic plaque), we have investi­
gated the profile of differentiation markers in several 
submerged keratinocyte culture systems. The aim of 
this study was to develop models that would resemble 
either the normal or the psoriatic pathway, as defined 
by the expression of the marker sets described above. 
In earlier experiments, we observed that the addition 
of fetal calf serum (FCS) to keratinocytes cultured in 
keratinocyte growth medium (KGM) resulted in the in­
duction of SKALP/elafin expression (Alkemade et al., 
1994). Recently, it was demonstrated that KGM de­
pleted of growth factors induces the expression of CK 
1 and CK10 in confluent cultures (Poumay and Pittel- 
kow, 1995). On the basis of these observations, we con­
sidered the possibility that distinct keratinocyte cul­
ture systems might be used as models for normal and 
psoriatic differentiation. We therefore investigated the 
effect of four culture media on confluent monolayers:
KGM alone (KGM), KGM with FCS (KGM/FCS), KGM
depleted of growth factors (KGM/-GF), and KGM with 
1.8 raM calcium (KGM/Ca). Our findings indicate that 
in these submerged culture systems, it is possible to 
approach the normal and psoriatic differentiation 
pathway,
MATERIALS AND METHODS
B iopsies
Biopsies (0.2 mm thickness) from healthy volunteers 
were taken with a keratome as previously described
(Schalkwijk et al., 1990) and used for primary keratino­
cyte cultures.
K eratinocyte prim ary culture
Human epidermal keratinocytes were initially cul­
tured according to the Rheinwald-Green system 
(Rheinwald and Green, 1975). Primary cultures of ker­
atinocytes were seeded on lethally irradiated (3,000 
rad, 3 min) Swiss mouse 3T3 fibroblasts in DMEM/F12 
(3:1) (v/v) (Flow Laboratories, Irvine, UK) supple­
mented with 0.4 (ng/ml hydrocortisone (Collaborative 
Research, Inc., Lexington, MA), isoproterenol (10~6 M) 
(Sigma, St. Louis, MO), 100 U/ml penicillin plus 100 
fjbg/ml streptomycin (Gibco, Breda, The Netherlands), 
6% fetal calf serum (FCS) (Seralab, Nistelrode, The 
Netherlands), and 10 ng/ml epidermal growth factor 
(EGF) (Sigma). Cells were grown at 37°C, 95% relative 
humidity, and 8% C 02 in air. EDTA-treated, trypsin- 
ized, and liquid nitrogen-stored keratinocytes from the 
primary culture were used in further experiments.
F irst passage and induction  of 
k eratin ocyte  d ifferentiation
For the experiments the human keratinocytes were 
seeded at 10 cells in KGM in 60 mm culture dishes as 
described before (van Ruissen et al., 1994). KGM was 
composed of KBM (Clonetics, San Diego, CA; 0.15 mM 
calcium) supplemented with ethanolamine (0.1 mM) 
(Sigma), phosphoethanolamine (0.1 mM) (Sigma), bo­
vine pituitary extract (BPE; 0.4% v/v) (Clonetics), epi­
dermal growth factor (EGF; 10 ng/ml) (Sigma), insulin 
(5 pg/ml) (Sigma), hydrocortisone (0.5 pg/ml) (Collabo­
rative Research, Inc.), penicillin (100 U/ml) (Gibco), and 
streptomycin (100 pg/ml) (Gibco).
Keratinocyte differentiation was induced by switch­
ing confluent keratinocyte cultures for 48 h to KGM 
supplemented with FCS (KGM/FCS), KGM depleted 
with growth factors (BPE, EGF, hydrocortisone, and 
insulin; KGM/-GF), and KGM containing high calcium 
(1.8 mM; KGM/Ca). As a control, we switched conflu­
ent keratinocyte cultures to KGM alone (KGM) for an­
other 48 h.
N orthern  b lotting
Total RNA was isolated from cultured human kera­
tinocytes and frozen keratome biopsies derived from 
normal healthy epidermis and psoriatic lesional epider­
mis. The normal volunteers had no personal or family 
history of psoriasis. The isolation was performed using 
RNAzol™, as suggested by the manufactor (Cinna/Bio- 
tex Laboratories, Inc., Houston, TX). RNAzol™ was 
added to either harvested and frozen (—80°C) keratino­
cyte cultures, viable keratinocyte cultures, or frozen 
keratome biopsies.
RNA concentrations were determined from the ab­
sorbance at 260 and 280 nm and equal quantities (10 
jug) of total RNA were electrophoretically separated in 
a 1% agarose gel (dissolved in 10 mM sodium phosphate 
buffer; pH = 7.0), as described in Maniatis (Sambrook 
et al., 1989), Gels were run submerged in 10 mM so­
dium phosphate buffer. The pH of the electrophoresis 
buffer was kept within acceptable limits by constant 
circulation of the buffer. The gels were blotted using 
10X SSC (1.5 M sodium chloride, 0.15 M sodium ci­
trate). After transfer, membranes were washed in 2x  
SSC, and RNA was crosslinked using ultraviolet irradi­
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ation (312 nm, 0.2 J/cm2). Membranes were incubated 
with ethidiumbromide (1 jug/ml) for 15 min prior to 
photography.
Filters were (pre)hybridized at 65°C according to 
Church and Gilbert (1984). Hybridizations were per­
formed overnight, filters were washed for 30 min using 
125 mM sodium phosphate buffer and 40 mM sodium 
phosphate buffer. Autoradiography was performed on 
X-Omat S films (Kodak) at -80°C with intensifying 
screens. Filters were hybridized with 32P-labelled ran-* 
dom primed probes for SKALP, psoriasin, CK1, PA- 
FABP, and 28S ribosomal RNA. Processing of the auto­
radiographs was performed using the Imagemaster™ 
data image system (Pharmacia LKB Biotechnology AB, 
Uppsala, Sweden).
Im m unocytochem ical sta in in g  o f hum an  
keratinocytes cu ltu red  on  coverslips
Immunocytochemical stainings were performed us­
ing the Vectastain ABC kits for monoclonal and poly­
clonal antibodies purchased from Vector Laboratories, 
Inc. (Burlingame, CA). For these stainings, we used 
the following polyclonal antibodies; anti-SKALP (SSK- 
9201), anti-human involucrin (BT-601; Biomedical 
Technologies, Inc,, Stoughton, MA) and monoclonal an­
tibodies; anti-keratin 10 (RKSE-60), anti-keratin 16 
(LL025), and anti-human keratinocyte transglutami­
nase (BT-621, Biomedical Technologies, Inc.). In brief, 
human keratinocytes were cultured on tissue culture 
coverslips (Thermanox, LAB-TEK Division, Miles Lab­
oratories, Inc., Naperville, IL) using different culture 
conditions. Cells were fixed using either 1% formalde­
hyde (freshly prepared from paraformaldehyde) or 
aceton/methanol (50/50) as determined by previous ex­
periments. Cells were stored at — 20°C. Before usage, 
the cells were transferred to 4°C for 30 min and then 
air-dried at room temperature. Paraformaldehyde fixed 
cells were incubated for 15 min in 50 mM NH4C1 (in 
PBS, pH = 7,5), and aceton/methanol fixed cells were 
incubated for 15 min in PBS. Immunocytochemical 
stainings were performed according to the description 
of the manufactor (Vector Laboratories Inc.).
Im m unocytochem ical sta in in g  for
flow  cytom etry
SKALP. About 105 formaldehyde (1%) fixed cells 
were washed once with PBS containing 1% newborn 
heat inactivated calf serum (NHICS). After sedimenta­
tion, the cells were incubated with a polyclonal anti­
body against SKALP (1:500) for 30 min at room temper­
ature. After washing, the cells with PBS/NHICS cells 
were incubated for 30 min at 37°C with goat-anti-rab- 
bit-biotinylated antibody (GARBIO; 1:200). Following 
this incubation, cells were washed and incubated with 
a complex of avidine and biotinylated phycoerythrin 
(PE) (1:100) (Vectastain ABC-Phycoerythrin kit, Vector 
Laboratories, Inc.) for 30 min at room temperature. 
Finally, cells were resuspended in 300 |til PBS con- 
taining 10'6M TO-PRO-3 (as previously described by 
van Hooijdonk et al., 1994) and incubated for 15 min 
with 50 |_tl of 1% (w/v) RNAse A.
T ransglutam inase. The staining for transglutami­
nase was performed as described above with the excep­
tion that we used a monoclonal antibody against trans­
glutaminase (1:15) and a rabbit anti-mouse fluores- 
ceine isothiocyanate (RAM-FITC) antibody to visualize
transglutaminase. The DNA content was determined 
with propidium iodide (PI) instead of TO-PRO-3.
Flow  cytom etry. Cells stained with propidium io­
dide or TO-PRO-3 and fluoresceine isothiocyanate 
(FITC) or phycoerythrin (PE) were analyzed on the 
Epics® Elite flow cytometer (Coulter Corporation, Hia­
leah, FL) equipped with a 25 mW argon-ion laser set 
at 15 raW and a 10 mW He/Ne laser. FITC and PI 
signals were separated by a 550 nm dichroic mirror. 
The FITC signals (green fluorescence) were detected 
through a 630 nm long pass filter. PE and TO-PRO-3 
signals were separated by a 625 nm dichroic mirror. 
The PE signals (orange fluorescence) were detected 
through a 575 nm band pass filter, and the TO-PRO- 
3 signals (pink/deep red fluorescence) were detected 
through a 675 nm band pass filter.
Usually 104 cells were measured at a flow rate of 
approximately 50 cells per second. The data were re­
corded in listmode and analyzed on the Epics® Elite 
workstation. The ratio area/peak of the red fluorescence 
is an excellent discriminator between artifacts due to 
doublets of diploid cells and real single tetraploid (or 
late S) cells when intact cells are used (Bauer and 
Boezeman, 1983).
RESULTS
First passage normal human keratinocytes were cul­
tured using serum-free KGM. When cultures reached 
confluence, they were switched to KGM/FCS, KGM/- 
GF, or KGM/Ca and cultured for another 48 h. For 
comparison, confluent cultures were kept in KGM alone 
for 48 h, which does not allow a significant degree of 
keratinocyte differentiation. Expression of SKALP/ 
el afin, CK10, involucrin, transglutaminase, and CK16 
was studied by immunocytochemistry. SKALP/elafin, 
CK1, psoriasin, and PA-FABP were studied on North­
ern blots. Flow cytometry was used to measure cell 
cycle parameters, and to quantify and further charac­
terize the SKALP/elafin-positive cell population.
Im m unocytochem istry
In the differentiated compartment of normal human 
epidermis involucrin, CK10, and transglutaminase are 
expressed whereas SKALP/elafin and CK16 are absent. 
In lesional psoriatic epidermis there is an increased 
expression of involucrin and transglutaminase due to 
a premature expression in the spinous layers. In con­
trast to normal epidermis, SKALP and CK16 are ex­
pressed at high levels in the suprabasal layers of le­
sional psoriatic epidermis, as shown previously. When 
confluent keratinocyte cultures grown in KGM were 
maintained in KGM for another 48 h, only a limited 
amount of cells is induced to differentiate. In this sys­
tem, CK10 expression is absent (Fig. la), while involu­
crin and SKALP are expressed only by a few scattered 
cells (Figs. 2a, 3a). CK16 and tranglutaminase are ex­
pressed by a small population of cells that show a 
rather intense staining (Figs, 4a, 5a).
Switching confluent keratinocyte cultures to KGM/ 
FCS for 48 h results in a strong upregulation of SKALP 
and involucrin expression (Figs. 2b, 3b) in a distinct 
population of large polygonal cells on top of the basal 
cell layer. Also, the number of cells expressing trans­
glutaminase and CK16 is strongly increased (Figs. 4b, 
5b), although the staining intensity in the positive cells 
is less than in the small population of transglutaminase
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Fig. X. Immunocytochemical staining for CK10 on human keratino- 
cytes cultured on coverslips under four different culture conditions. 
KGM (a), KGM/FCS (b), KGM/-GF (c), and KG3VI/Ca (d). Only in 
KGM/-GF a significant number of CK10 positive colonies were found 
at 48 h. At 72 h, the entire suprabasal layer was positive for CK10 
(not shown).
Fig. 2. Immunocytochemical staining for SKALP on human kera- 
tinocytes cultured on coverslips under four different culture condi­
tions. KGM (a), KGM/FCS (h), KGM/-GF (c), and KGM/Ca (d). Note 
the strong staining for SKALP in the large polygonal cell population 
cultured in KGM/FCS.
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Fig. 3. Immunocytochemical staining for involucrin on human kera- Fig. 4. Immunocytochemical staining for transglutaminase on hu~
tinocytes cultured on coverslips under four different culture condi- man keratinocytes cultured on coverslips under four different culture
tions. KGM (a), KGM/FCS (b), KGM/-GF (c), andKGM/Ca (d)< Involu- conditions. KGM (a), KGM/FCS (b), KGM/-GF (c), and KGM/Ca (d)f
crin-positive cells were found in all three models for differentiation, Note that transglutaminase is abundantly expressed in all three dif-
whereas only a few scattered involucrin-positive cells were found in ferentiation models, whereas in KGM alone, only a few cells are posi-
KGM alone tively expressed.
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Fig, 5. Immunocytochemical staining for CK16 on human keratino- 
cytes cultured on coverslips under four different culture conditions. 
KGM (a), KGM/FCS (b), KGM/-GF (c), and KGM/Ca (d). Note that 
in KGM/FCS and KGM/Ca nearly the entire plate is covered by moder­
ately CK16-positive cells, whereas in KGM and KGM/-GF the number 
of cells is much smaller but the staining is more intense.
or CK16 positive cells in KGM alone (compare Figs. 
4a-b and 5a-b). Addition of FCS does not induce ex­
pression of CK10 (Fig. lb).
When confluent cultures were switched to KGM/-GF, 
only a few cells expressed SKALP (Fig. 2c). The expres­
sion of SKALP in this system is comparable to cultures 
switched to KGM alone, but is strongly decreased com­
pared to cultures switched to KGM/FCS* The number 
of cells that express involucrin is far lower than in 
KGM/FCS, and is only slightly higher than in KGM 
alone (Fig. 3c), It was noted that the intensity of involu­
crin staining increased in cultures switched to KGM/- 
GF compared to KGM/FCS, and that cells differ mor­
phologically from cells cultured in KGM alone. Growth 
factor depletion results in striking differences com­
pared to the other culture systems. After 48 h, a popula­
tion of cells expresses CK10 (Fig. lc), and after 72 h, 
nearly all suprabasal cells are CK10 positive (not 
shown). Cytokeratin 16 is expressed by a somewhat 
larger population of cells compared to KGM alone (Fig. 
5c). Although the number of CK16-positive cells in 
KGM/-GF is smaller than in KGM/FCS, the intensity 
of CK16 staining in the positive population is markedly 
higher (compare Fig. 5b—c).
The expression level of involucrin and transglutami­
nase in keratinocytes cultured in KGM/Ca was strongly 
increased compared to KGM alone and was comparable 
to cultures switched to KGM/FCS (Figs, 3d, 4d). The 
number of cells expressing SKALP, however, was low 
and is comparable to culture conditions with KGM 
alone. The expression of CK16 (Fig. 5d) is increased 
compared to cultures switched to KGM and very few 
cells are expressing CK10 (Fig. Id). Results from the 
immunocytochemical stainings are summarized in Ta­
ble 1. Data on expression levels in vivo are taken from 
the literature, but were independently confirmed by us 
(not shown).
N orthern  blot analysis
In order to confirm and extend these immunocyto­
chemical observations, Northern blots were hybridized 
using probes for SKALP, CK1, psoriasin, and PA-FABP 
(results are summarized in Table 2). Using these differ­
ent markers it is clear that in normal epidermis (Fig. 
6, lane 1) expression of SKALP, PA-FABP, and psoria­
sin is low to undetectable, and CK1 is present. In con­
trast to normal epidermis, psoriatic lesional epidermis 
(Fig. 6, lane 2) shows a strong expression of SKALP, 
PA-FABP, and psoriasin.
Switching confluent human keratinocyte cultures to 
KGM for another 48 h (Fig. 6, lane 3) shows moderate 
expression of SKALP. The expression of SKALP is 
partly dependent on the confluency of the culture, since 
sub confluent cultures are negative for SKALP (data not 
shown). These cultures show a faint expression of PA- 
FABP and do not allow the expression of psoriasin 
or CK1.
In KGM/FCS (Fig. 6, lane 4) a strong upregulation 
of SKALP expression is seen. Using this system, a weak 
expression of PA-FABP and psoriasin is detectable. Un­
der these culture conditions, CKl is not expressed.
In contrast to keratinocytes cultured in KGM or 
KGM/FCS, CKl expression is strongly induced when 
confluent cultures were switched to KGM/-GF for 48 
h (Fig. 6, lane 5). This system further results in the 
downregulation of SKALP expression to nearly unde-
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TABLE 1 . Summary of the immunocytochemical stainings performed on human keratinocytes cultured on coverslips1
KGM KGM/FCS KGM/-GF KGM/Ca Normal epidermis2
Lesional psoriatic 
epidermis2
SKALP + /- + + + / - + / - + +
Involucrin + /— + + + -f- + +
CK1Ö + /- + +
CK16 + + + + J + + H- — +
Transglutaminase + 3 + + + + + + 4* +
^ h e  results are semiquantitative on a 4-point acale indicating absence of positive cells (~), few positive cells ( + ), many positive cells (+ + ), nearly complete covering
of the plate with positive cells { + + + ).
2Data taken from the literature and confirmed by us.
3In these cultures, a relatively small population of intensely stained cells is present.
TABLE 2, Summary of the Northern blot analyses performed on total RNA isolated from 
keratinocytes cultured under the various conditions
KGM KGM/FCS KGM/-GF KGM/Ca Normal epidermis1
Lesional psoriatic 
epidermis1
SKALP + + 4- + - /+ +
CK1 — --- + / - + +
Psoriasin — + /-- — — — + + +
PA-FABP + / - —/+ - /+ +
'Data taken from the literature and confirmed by us.
28S
SKALP
Keratin 1
PA-FABP
Psoriasin
Fig. 6 . Northern blot analysis of cultured human keratinocytes com­
pared to normal epidermis and lesional psoriatic epidermis. Total 
RNA was isolated from normal epidermis (lane 1), lesional psoriatic 
epidermis (lane 2), keratinocytes cultured in KGM (lane 3), keratino­
cytes cultured in RGM/FCS (lane 4), keratinocytes cultured in KGM/- 
GF (lane 5), and keratinocytes cultured in KGM/Ca (lane 6 ). Hybrid­
izations were performed using probes for PA-FABP, CK1, SKALP, 
Psoriasin, and 28S ribosomal RNA to check for equal loading.
tectable levels when compared to KGM alone. Further­
more, we see a strong upregulation of PA-FABP in cul­
tures depleted of growth factors. The high expression 
level of PA-FABP in KGM/-GF is the only marker which 
does not match the pattern found in vivo.
Using culture conditions with high calcium (Fig. 6, 
lane 6) there is moderate expression of SKALP, which 
is comparable to the expression of SKALP in cultures 
switched to KGM. In this system, a very weak expres­
sion of CK1 and PA-FABP is detectable.
Flow cytom etry
In addition to immunocytochemical stainings and 
Northern blot analysis, we applied flow cytometry to 
study cell cycle parameters under these four culture 
conditions. Keratinocytes in KGM, KGM/FCS, and 
KGM/Ca had similar relative DNA distributions as de­
termined by propidium iodide staining. The percent­
ages of cells in S-phase were 20.9, 18.1, and 24.2%, 
respectively, indicating that these cultures were still 
hyperproliferative. However, when using KGM/-GF the 
percentage of cells in S-phase dropped to 11.2%, indi­
cating that these cultures were relatively quiescent 
compared to the other models.
The immunocytochemical data presented in Figures
1—5 only provide semi-quantitative data on expression 
of the selected antigens. In order to obtain quantitative 
data, we performed flow cytometric measurements of 
SKALP and transglutaminase. Figure 7b shows a dot 
plot of SKALP positive cells (phycoerythrin fluores­
cence on the Y-axis) against the right angle scatter (X- 
axis) which is a measure for cell size. From this figure, 
it can been seen that the mean right angle scatter of 
the SKALP-positive cells (window R3) is shifted to the 
right compared to the negative cells (window R2) indi­
cating that the SKALP positive cells are, on average, 
bigger than the SKALP negative cells. The SKALP pos­
itive population (window R3) comprises about 22% of 
the total population (windows R2 + R3). Figure 8 dem­
onstrates the transglutaminase expression under our 
culture conditions. These figures show that when sub­
confluent cultures were cultured to post confluence, 
their transglutaminase expression increased from 1.3 
to 6.5%. Switching confluent cultures to KGM/-GF or 
KGM/Ca results in a population of transglutaminase 
positive cells of 8.6 and 12.4%, respectively. The largest 
increase in transglutaminase expression was obtained 
when confluent cultures were switched to KGM/FCS. 
In this system, we see a population of transglutaminase 
positive cells that comprises 28.4% of the total cell pop-
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Fig. 7. Flow cytometric characterization of SKALP positive keratino- 
cytes. Human keratinocytes were cultured in KGM/FCS, trypsinized, 
fixed in paraformaldehyde and immunocytochemically stained for 
SKALP. The control staining (left) was used to discriminate between 
negative (window R2) and positive cells (window R3) in the population
stained for SKALP (right). On the Y-axis: fluorescence of the phycoer- 
ythrin signal; on the X-axis: the right angle scatter which is an indicator 
for cell size. Note that the SKALP-positive population is slightly shifted 
to the right compared to the negative cells, indicating that the SKALP 
positive cells are, on average, bigger than the SKALP-negative cells.
illation. The quantitative data are in accordance with 
the immunocytochemical results.
D IS C U S S IO N
Culture systems for human keratinocytes have pro­
vided useful models to study cellular control of epider­
mal growth and differentiation in vitro. However, none 
of the systems that are commonly used, either sub­
merged or air-exposed, exactly matches the phenotype 
found in normal human epidermis. Submerged cultures 
such as the Rhein wald-Green system or the serum-free 
KGM system allow exponential growth, but only a lim­
ited amount of normal differentiation. Air-exposed cul­
tures, although they provide a stratified morphology 
which resembles normal epidermis, are phenotypically 
abnormal in that they are characterized by the expres­
sion of cytokeratin 6/16, SKALP/elafin, and presence of 
involucrin and transglutaminase in the spinous layers, 
as we and others have previously shown (Alkemade et 
aL, 1994; Ponec, 1991). The air-exposed models are, 
therefore, more similar to hyper proliferative epidermis 
(as found in psoriasis and injured skin) than to normal 
epidermis. Although the air-exposed systems are ele­
gant models for reconstructing the tissue in vitro, a 
serious drawback is that they are not suitable for large 
scale screening purposes and for experimental manipu­
lation such as transient transfection.
The aim of our study was to obtain keratinocyte cul­
ture models that could be used to study the normal and 
the psoriatic differentiation pathway. Since we in­
tended to use these models for large scale cell biological 
and pharmacological studies, we opted for submerged
culture conditions in the KGM system. Using three 
models for induction of differentiation (addition of FCS, 
depletion of growth factors, and high Ca++), we have 
studied proliferative rates and the expression levels 
of differentiation-related molecules associated with the 
normal and the psoriatic phenotype. All three models 
share a number of differentiation characteristics, as 
assessed by morphological criteria (appearance of a su- 
prabasal layer of large polygonal cells) and the expres­
sion of involucrin and transglutaminase type 1. How­
ever, we found that none of the models exactly follows 
the normal or the psoriatic profile of differentiation 
markers, and each model displayed a distinct combina­
tion of differentiation-related molecules. However, two 
models stand out that appear to be suitable for further 
study, as they closely follow the expression of markers 
that are typical for either differentiation pathway. Cy­
tokeratin 16, SKALP/elafin, and psoriasin are mole­
cules that are not expressed in normal epidermis, but 
are highly expressed in psoriatic epidermis. As shown 
in Table 1, induction of differentiation by the addition 
of FCS is characterized by high expression levels of 
these molecules compared to undifferentiated cultures 
(KGM alone) and compared to the other differentiation 
models. We, therefore, suggest that induction of differ­
entiation by FCS could be a useful model for the psori­
atic phenotype. When differentiation is induced by 
depletion of growth factors, a model which was recently 
described by Poumay and Pittelkow (1995), SKALP ex­
pression is very low, psoriasin expression is undetect­
able, whereas cytokeratin 1 and 10 are expressed. The 
marker profile of these cells is similar to that found in
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Fig. 8 . Flow cytometric characterization of transglutaminase posi­
tive keratinocytes. Human keratinocytes were cultured in different 
models, trypsinized, fixed in acetone/methanol and imrnunocyto chem- 
ically stained for transglutaminase. The control staining (panel A) 
was used to discriminate between negative (window R2 ) and positive 
cells (upper window) in the population stained for transglutaminase). 
On the Y-axis: fluorescence of the FITC signal; on the X-axis: the right
angle scatter which is an indicator for cell size. The percentage of 
transglutaminase positive cells was determined in the following cul­
tures: (A) subconfluent culture in KGM (control panel), (B) subcon­
fluent culture in KGM; the following panels represent confluent cul­
tures switched to (C) KGM for another 48 h, (D) KGM/FCS for another 
48 h, (E) KGM/-GF, and (F) KGM/Ca.
normal epidermis, and we suggest that this could be a 
useful model to study the normal differentiation path­
way. In addition to the profile of differentiation mark­
ers, the proliferative status of these two models also 
resembles the in vivo situation. In KGM/FCS, a high 
proliferative rate is maintained, whereas in KGM/-GF 
cells appear to be quiescent. Quiescence in this model, 
however, has to be interpreted with some caution since 
a number of cells do not accumulate in Go, but are 
scattered randomly over the cell cycle phases, as we 
have shown before (van Ruissen et al., 1994). The third 
model, using a high Ca++ concentration, is the least 
specific and displays a marker profile which is interme­
diate between the other two models. In addition to the 
aforementioned markers, we also studied the expres­
sion of PA-FABP, which is a lipid transport molecule 
expressed in the stratum granulosum of normal epider­
mis, and throughout the suprabasal layers of psoriatic 
epidermis. PA-FABP expression does not follow the 
pattern found for most other markers, as it is highly 
expressed in the growth factor depleted cultures and
expressed at low levels in the FCS treated cultures. A 
possible explanation for the induction of PA-FABP 
could be that the growth factor depleted cultures have 
no lipid source in the medium, whereas the other two 
media have lipids or lipid precursors present (FCS and/ 
or BPE). Previous studies by others have documented 
the relationships between epidermal differentiation 
and lipid metabolism (Brod et al., 1991; Boyce and Wil­
liams, 1993; Schurer et al., 1994; Larsen et al., 1994). 
As shown in figure 5 and Table 1, a considerable num­
ber of cytokeratin 16 positive cells was present in con­
fluent cultures in KGM alone and in all three differenti­
ation models. Expression of cytokeratin 16 appears to 
be a function of cell density rather than being under 
control of the culture media used (not shown). It was 
recently described by others that control of keratino- 
cyte commitment to terminal differentiation, and the 
expression of selected differentiation genes are medi­
ated by cell confluence and by specific culture factors. 
It also shows that induction of differentiation was inde­
pendent of the calcium concentration, and the presence
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of growth factors inhibited cytokeratin 1 and 10 gene 
expression (Poumay and Pittelkow, 1995). In this 
study, we confirmed these findings.
The finding that addition of serum could induce ex­
pression of psoriasis associated markers could very well 
be relevant for the in vivo situation. We and others 
have found that during inflammation (wound healing, 
psoriasis) the epidermis becomes more permeable to 
plasma derived proteins (Andriessen et al., 1995; 
Verschoore et al., 1990). Speculatively, epidermal hyper­
proliferation and abnormal differentiation as seen in 
psoriasis could be induced by the presence of growth 
factors and cytokines from the interstitial fluid and 
plasma. In this study, we have used FCS for induction 
of psoriatic differentiation; we have found, however, 
that human serum is equally effective in inducing 
SKALP expression both at the protein and mRNA level 
(data not shown).
In vitro systems for keratinocyte culture can be used 
to study the cell biology of epidermal differentiation 
and to characterize the factors that regulate expression 
levels of individual genes or coordinated expression of 
sets of genes. Alternatively these systems can be used 
for large scale screening of drugs. We are currently 
using the models on a smaller scale (96-well plates) to 
test the effect of drugs on selected differentiation genes. 
Preliminary results indicate that, in this system, the 
effect of retinoids and retinoid-like compounds can be 
easily screened using downregulation of SKALP and 
transglutaminase as a read-out in a direct cell-ELISA 
as described by others (Daneels et al., 1994). Ideally, 
we would like to obtain culture systems with predictive 
power concerning the effects of drugs on keratinocyte 
differentiation in vivo. Future studies will be aimed 
at further refining of the models by adjusting the cell 
density and the lipid availability in order to match the 
marker profiles of the in vitro system more closely to 
the in vivo differentiation pathways.
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